Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02037061 · ClinicalTrials.gov registry record · NA
Reducing Post-Op Pain After Sacrospinous Ligament Colpopexy
A NA study, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- NA
- Development phase
- 46
- Enrollment target
NCT02037061: Completed NA study, sponsored by The Cleveland Clinic.
NCT02037061 is a NA study that has completed, run by The Cleveland Clinic. The registered enrollment target is 46 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02037061, a NA study, has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 46 participants
- Enrollment target
Study Summary
This is a randomized controlled trial to determine if intraoperative local analgesia administered at the level of the sacrospinous ligament can lessen the gluteal pain felt by patients postoperatively after SSL colpopexy. Hypothesis: Local analgesia administered at the level of the sacrospinous ligament can lessen the gluteal pain felt by patients postoperatively after SSL colpopexy.
Primary Outcome
Pain measured using a pain numeric rating scale from 0 to 10 (0=no pain, 10= worst pain imaginable)
Interventions
- DRUG Bupivacaine
- OTHER Normal Saline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2014-03 |
| Est. Completion | 2016-07 |
| Phase | NA |
What the finished NCT02037061 record still lists
NCT02037061 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 46 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 2 interventions - of which Bupivacaine is the first listed.
NCT02037061 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02037061 about?
NCT02037061 is a clinical study titled "Reducing Post-Op Pain After Sacrospinous Ligament Colpopexy". This is a randomized controlled trial to determine if intraoperative local analgesia administered at the level of the sacrospinous ligament can lessen the gluteal pain felt by patients postoperatively after SSL colpopexy. Hypothesis: Local analgesia administered at the level of the sacrospinous lig...
What is the current status of trial NCT02037061?
This trial is currently completed. It is a NA study. The enrollment target is 46 participants. The study started on 2014-03. Estimated completion is 2016-07.
What interventions are being tested in trial NCT02037061?
The interventions under investigation include: Bupivacaine (DRUG), Normal Saline (OTHER).
Who is sponsoring clinical trial NCT02037061?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02037061's enrollment target sits among peer trials
46 1402nd of 2000 higher than 590 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01890590 · 46 participants · NA
A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma
- NCT03191149 · 46 participants · Phase 2
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
- NCT03510208 · 46 participants · Phase 1
Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery
- NCT04048278 · 46 participants · Early Phase 1
Lidocaine Infusion in Pancreatic Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia